US Loses Measles Elimination Status After 25 Years, WHO Body Rules

Here the data raises a flag. In the U.S., roughly 1 to 3 of every 1,000 measles cases results in death. Pennsylvania has recorded just over 1,500 cases, which means its reported deaths run higher than expected. The likely explanation, experts say, is that the state's true case count hasn't been fully captured.

Why did elimination collapse?

"I do want to just stress that measles elimination has always been a tenuous prospect, and it is, by design, tenuous," said Maimuna Majumder, a distinguished scholar in the Computational Health Informatics Program at Boston Children's Hospital. "When January 2025 picked up, I felt like this might be the point of no return," she previously told Live Science.

Keeping an eliminated disease down requires sustained work. Because measles spreads so easily, at least 95% of the population needs immunity — through vaccination or past infection — to prevent large outbreaks. National vaccination rates have been falling for years, and only 10 states reported kindergarten rates above that immunity threshold for 2025-2026.

Experts point to a cluster of causes:

• Declining funds and staff for public health work
• Wavering public trust in vaccines and scientific expertise
• The appointment of vaccine skeptic Robert F. Kennedy Jr. as health secretary
• The loss of long-standing federal health leadership

Vaccine guidance has also been changed in ways that likely sow confusion, these experts say, while federal rhetoric now frames vaccine safety and effectiveness as open questions — though both are well-established scientifically. That's what is not being said loudly enough: the underlying evidence hasn't changed. The communication around it has.

What does this change for the public?

In practical terms, the revocation formalizes what the case counts already told us: measles now circulates on its own inside the U.S., so exposure risk no longer depends on international travel chains. And measles is not a benign childhood rite. Among survivors, it can cause long-term harm, including brain damage and "immune amnesia" — a wiping of the immune cells' memories of past infections, leaving people vulnerable to diseases they'd already fought off.

One scheduling detail deserves scrutiny. PAHO's meeting to reevaluate the U.S. status was originally set for April but was pushed to November, delaying the formal verdict by roughly seven months while cases climbed.

Regaining the status is simple to state and hard to do: the U.S. must go 12 months without continuous spread of the virus. Given that 2026 has already produced more than double last year's cases, that clock hasn't even started. Every promise of a quick turnaround comes with the same caveat — it depends on vaccination rates most states currently don't have.

This article is for informational purposes only and is not meant to offer medical advice.